Puyang Refractories Group Inkomsten in het verleden
Verleden criteriumcontroles 0/6
Puyang Refractories Group's earnings have been declining at an average annual rate of -6.6%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 7.2% per year. Puyang Refractories Group's return on equity is 4.6%, and it has net margins of 3%.
Belangrijke informatie
-6.6%
Groei van de winst
-7.2%
Groei van de winst per aandeel
| Chemicals Groei van de industrie | 12.1% |
| Inkomstengroei | 7.2% |
| Rendement op eigen vermogen | 4.6% |
| Nettomarge | 3.0% |
| Laatste winstupdate | 30 Sep 2024 |
Recente prestatie-updates uit het verleden
Puyang Refractories Group's (SZSE:002225) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Nov 04
We Think You Should Be Aware Of Some Concerning Factors In Puyang Refractories Group's (SZSE:002225) Earnings
Apr 05Recent updates
Puyang Refractories Group's (SZSE:002225) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Nov 04Puyang Refractories Group Co., Ltd.'s (SZSE:002225) 26% Dip In Price Shows Sentiment Is Matching Earnings
Jun 24Puyang Refractories Group Co., Ltd. (SZSE:002225) Held Back By Insufficient Growth Even After Shares Climb 28%
May 09We Think You Should Be Aware Of Some Concerning Factors In Puyang Refractories Group's (SZSE:002225) Earnings
Apr 05Opbrengsten en kosten
Hoe Puyang Refractories Group geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Sep 24 | 5,425 | 163 | 518 | 235 |
| 30 Jun 24 | 5,540 | 236 | 515 | 218 |
| 31 Mar 24 | 5,553 | 269 | 549 | 212 |
| 31 Dec 23 | 5,473 | 248 | 550 | 200 |
| 30 Sep 23 | 5,259 | 222 | 532 | 179 |
| 30 Jun 23 | 5,029 | 205 | 522 | 192 |
| 31 Mar 23 | 5,016 | 199 | 526 | 192 |
| 01 Jan 23 | 4,936 | 230 | 514 | 199 |
| 30 Sep 22 | 4,787 | 144 | 516 | 223 |
| 30 Jun 22 | 4,723 | 134 | 475 | 210 |
| 31 Mar 22 | 4,481 | 80 | 429 | 202 |
| 01 Jan 22 | 4,378 | 84 | 428 | 189 |
| 30 Sep 21 | 4,422 | 211 | 428 | 145 |
| 30 Jun 21 | 4,288 | 252 | 445 | 153 |
| 31 Mar 21 | 4,233 | 302 | 433 | 169 |
| 31 Dec 20 | 4,174 | 300 | 439 | 176 |
| 30 Sep 20 | 4,087 | 294 | 502 | 181 |
| 30 Jun 20 | 4,081 | 288 | 559 | 180 |
| 31 Mar 20 | 4,016 | 264 | 617 | 181 |
| 31 Dec 19 | 4,140 | 252 | 663 | 193 |
| 30 Sep 19 | 4,161 | 258 | 781 | 184 |
| 30 Jun 19 | 4,125 | 231 | 695 | 188 |
| 31 Mar 19 | 4,099 | 232 | 690 | 183 |
| 01 Jan 19 | 3,888 | 222 | 637 | 169 |
| 30 Sep 18 | 3,676 | 148 | 588 | 173 |
| 30 Jun 18 | 3,487 | 89 | 528 | 216 |
| 31 Mar 18 | 3,129 | 42 | 526 | 169 |
| 31 Dec 17 | 2,815 | 22 | 532 | 135 |
| 30 Sep 17 | 2,593 | -208 | 525 | 98 |
| 30 Jun 17 | 2,416 | -179 | 594 | 0 |
| 31 Mar 17 | 2,367 | -179 | 597 | 0 |
| 31 Dec 16 | 2,339 | -185 | 579 | 0 |
| 30 Sep 16 | 2,361 | 24 | 580 | 0 |
| 30 Jun 16 | 2,466 | 37 | 604 | 0 |
| 31 Mar 16 | 2,638 | 66 | 619 | 0 |
| 31 Dec 15 | 2,794 | 85 | 643 | 0 |
| 30 Sep 15 | 2,839 | 167 | 592 | 0 |
| 30 Jun 15 | 2,790 | 172 | 563 | 0 |
| 31 Mar 15 | 2,678 | 167 | 543 | 0 |
| 31 Dec 14 | 2,611 | 162 | 527 | 0 |
| 30 Sep 14 | 2,607 | 158 | 519 | 0 |
| 30 Jun 14 | 2,571 | 151 | 523 | 0 |
| 31 Mar 14 | 2,502 | 135 | 501 | 0 |
| 31 Dec 13 | 2,432 | 122 | 485 | 0 |
Kwaliteitswinsten: 002225 has a large one-off gain of CN¥83.7M impacting its last 12 months of financial results to 30th September, 2024.
Groeiende winstmarge: 002225's current net profit margins (3%) are lower than last year (4.2%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: 002225's earnings have declined by 6.6% per year over the past 5 years.
Versnelling van de groei: 002225's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Winst versus industrie: 002225 had negative earnings growth (-26.5%) over the past year, making it difficult to compare to the Chemicals industry average (-3.8%).
Rendement op eigen vermogen
Hoge ROE: 002225's Return on Equity (4.6%) is considered low.